NCT05714891 - Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 15, 2023

Primary Completion Date

August 31, 2026

Study Completion Date

March 31, 2028

Conditions

NSCLC

Interventions

DRUG

JDQ443

Dose will be assigned at enrollment

Trial Locations (9)

BCCA - Vancouver, Vancouver

CancerCare Manitoba, Winnipeg

Kingston Health Sciences Centre, Kingston

London Health Sciences Centre Research Inc., London

Ottawa Hospital Research Institute, Ottawa

University Health Network, Toronto

CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal

The Research Institute of the McGill University, Montreal

University Institute of Cardiology and, Québec